Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4585877
Max Phase: Preclinical
Molecular Formula: C15H10Cl2N2
Molecular Weight: 289.17
Molecule Type: Unknown
Associated Items:
ID: ALA4585877
Max Phase: Preclinical
Molecular Formula: C15H10Cl2N2
Molecular Weight: 289.17
Molecule Type: Unknown
Associated Items:
Canonical SMILES: N#CCCn1c2ccc(Cl)cc2c2cc(Cl)ccc21
Standard InChI: InChI=1S/C15H10Cl2N2/c16-10-2-4-14-12(8-10)13-9-11(17)3-5-15(13)19(14)7-1-6-18/h2-5,8-9H,1,7H2
Standard InChI Key: UIPJGIGKJFHJMO-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 289.17 | Molecular Weight (Monoisotopic): 288.0221 | AlogP: 5.01 | #Rotatable Bonds: 2 |
Polar Surface Area: 28.72 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.30 | CX LogD: 4.30 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.65 | Np Likeness Score: -1.18 |
1. (2016) Modulation of k2p channels, |
Source(1):